Supports skin clarity, elasticity, and visible firmness
Orforglipron In phase II, randomized, double-blind study, adults with overweight or obesity and without T2DM who took oral orforglipron (12, 24, 36, or 45 mg) daily for 36 weeks experienced a weight reduction of 9.414.7% [105]
k , Glucose tolerance test on day 4
Association between junk food consumption and mental health problems in adults: a systematic review and meta-analysis
It potentially addresses one of the upstream drivers of the disease itself
this phenomenon is also known as oxidative stress